Analysis of Recombinant Human Bone Morphogenetic Protein-2 Use in the Treatment of Lumbar Degenerative Spondylolisthesis
Conclusions Our data shows that the revision rates were significantly lower in patients treated with rhBMP-2 compared with patients not treated with rhBMP-2. Furthermore, rhBMP-2 use in LDS varied by year, region, gender, and type of fusion technique. In the West region, the posterior approach and patients 65 to 69 years of age had the highest rate of rhBMP-2 use.[...]Georg Thieme Verlag KG Stuttgart · New YorkArticle in Thieme eJournals:Table of contents | Abstract | open access Full text
Source: Global Spine Journal - Category: Orthopaedics Authors: Yao, QingqiangCohen, Jeremiah R.Buser, ZoricaPark, Jong-BeomBrodke, Darrel S.Meisel, Hans-JoergYoussef, Jim A.Wang, Jeffrey C.Yoon, S. Tim Tags: Original Article Source Type: research